Human Monkeypox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention

Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das

doi:10.55927/ijis.v3i3.7337

Authors

Rehan Haider University of Karachi
Asghar Mehdi Fazaia Ruth Pfau Medical College, Shahrahe Faisal Karachi
Anjum Zehra Univesity of Karachi
Geetha Kumari Das University Rajasthan

DOI:

https://doi.org/10.55927/ijis.v3i3.7337

Keywords:

Human Monkeypox, Monkeypox Virus, Orthopoxvirus, Epidemiology

Abstract

Human monkeypox is a unique fervid disease caused by a monkeypox bacterium, an appendage of the Orthopoxvirus genus. Affliction exhibits epidemiological and dispassionate traits that pose challenges for disease and prevention. Primarily native to the Central and West African domains, monkeypox has gained worldwide attention because of occasional outbreaks and the potential for human-to-human broadcast. Epidemiologically, monkeypox shares similarities with smallpox, including reservoirs likely to contain rodents and non-human anthropoids. The virus may be transmitted to people through direct contact with infected mammals or bodily fluids. Person-to-person broadcasts, even though meager, contribute to the spread of ailments, stressing the need for active stopping strategies. Clinical evidence of human monkeypox includes delirium, problems, muscle aches, and a characteristic rash. The range of ailment asperity ranges from mild, self-confining cases to harsh forms accompanying obstacles, underscoring the importance of correct and appropriate diseases. However, distinguishing monkeypox from other rash ailments, including smallpox and chickenpox, is a challenge. The prevention of human monkeypox relies on early discovery and immunization. Surveillance works aim to monitor and contain outbreaks, whereas expeditious demonstrative tests influence up-to-the-minute case identification. Vaccination, accompanying the existing smallpox cure, has proven promising in preventing monkeypox and lowering the severity of the affliction. However, continuous research is crucial to evolving guide attacks, particularly given the disadvantages of the smallpox cure and the progressing type of virus

Downloads

Download data is not yet available.

References

An update on the monkeypox outbreak in Nigeria in 2018. available at:https://ncdc.gov.ng/diseases/sitreps/?cat58&name5Anpercent20Updatepercent20ofpercent20Monkeypoxpercent20Outbreakpercent20in%20

Breman JG, Kalisa R, Steniowski MV, et al. Human monkeypox, 1970-79. Bull International Health Organ 1980; 58: 165–82.

Bera BC, Shanmugasundaram K, Barua S, et al. Zoonotic cases of camelpox infection in India. Vet Microbiol 2011; 152:29–38.

Cook dinner, GC, Zumla A. bankruptcy 47. Cutaneous viral diseases, monkeypox. In: Cook GC, Zumla A, editors. Manson’s tropical diseases. 22nd edition. London: Harcourt Brace Saunders, Publishing organization; 2009. p. 839–

Carlin EP, Giller N, Katz R. Estimating the size of the U.S. population at risk of severe adverse events from replicating the smallpox vaccine. Public Health Nurs 2017; 34:200–9.

Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of monkeypox—Illinois, Kansas, Missouri, Ohio, and Wisconsin, 2003.

CDC. Monkeypox. MMWR Morb Mortal Wkly Rep 2018;67:306–10.

Doshi RH, Guagliardo SAJ, Dzabatou-Babeaux A, et al. Strengthening of surveillance during the monkeypox outbreak, Republic of the Congo, 2017. Emerg Infect Dis 2018;24:1158–60.

Doty JB, Malekani JM, Kalemba LN, et al. Assessing monkeypox virus occurrence in small mammals at the human-animal interface within the Democratic Republic of the Congo. Viruses 2017;9(10) [pii:E283].

Davies DH, Liang X, Hernandez JE al. Profiling the humoral immune response to infection by 75 using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 2005;102:547–52.

Damon IK. The popularity of human monkeypox: medical disorder, epidemiology, and studies. Vaccine 2011;29(Suppl 4):D54–9. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis 2014; 58:260–7.

Davies DH, Molina DM, Wrammert, et al. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 2007;7:1678–86.

Di Giulio DB, Eckburg PB. Human monkeypox: a rising zoonosis. Lancet 2004;4:15–25.

Durski KN, McCollum AM, Nakazawa Y, et al. The emergence of Monkeypox—West and Central Africa, 1970–2017. MMWR Morb Mortal Wkly Rep 2018; 67:306–10.

Eteng WE, Mandra A, Doty J, et al. Notes from the field: responding to an outbreak of monkeypox using the one health approach—Nigeria, 2017–2018. MMWR Morb Mortal Wkly Rep 2018;67:1040–1. 58. Nigerian CDC.

Eckart RE, Love SS, Atwood JE, et al., Department of Defense Smallpox Vaccine Nation Clinical Evaluation Team. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 2004;44: 201–5.

Formenty P, Muntasir MO, Damon I, et al. Human monkeypox outbreak as a result of a novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg Infect Dis 2010; 16:1539–45.

Facilities for illness management and prevention (CDC). replace the multistate outbreak of monkeypox in Illinois, Kansas, Missouri, Ohio, and Wisconsin in 2003. MMWR Morb Mortal Wkly Rep 2003;52(27):642–6.

Faye O, Pratt CB, Faye M, et al., Genomic characterization of the human monkeypox virus in Nigeria. Lancet Infect Dis 2018;18:246.

Jezek Z, Szczeniowski M, Paluku KM, et al. Human monkeypox: confusion with chickenpox. Acta Trop 1988;45:297–307.

Fenner F, Henderson DA, Arita I, et al., Smallpox and its Eradication. Geneva (Switzerland): Global Health Agency; 1988.

First-class PE, Jezek Z, Clutch B, et al.: The transmission capacity of the monkeypox virus in human populations. Int J Epidemiol 1988;17:643–50.

Found out: Reynolds MG, Wassa DW, et al. Prolonged interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 2005;73:428–34.

Gordon SN, Cecchinato V, Andresen V, et al. Smallpox vaccine protection is dependent on T cells and not B cells. J Infect Dis 2011;203:1043–53.Huhn

GD, Bauer AM, Yorita Okay, et al. Scientific characteristics of human monkeypox and chance elements for extreme sickness. Clin Infect Dis 2005;41:1742–51.

Gispen R, Verlinde JD, and Zwart P. Histopathological and virological research on mon key pop. Arch Gesamte Virusforsch 1967;21:205–16.

Gilchuk I, Gilchuk P, Sapparapu G, et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell 2016;167:684–94.

Hutin YJ, Williams RJ, Malfait P, et al. The outbreak of human monkeypox, Democratic

Hoff NA, Doshi RH, Colwell B, et al. Evolution of a sickness surveillance gadget: an increase in reporting of human monkeypox illness inside the Democratic Republic of the Congo, 2001–2013. Int J Trop Dis fitness 2017;25 [pii: IJTDH.35885].

Hutson CL, Lee KN, Abel J, et al., Monkeypox Zoonotic Institutions: Insights from Laboratory Assessment of Animals Related to the Multi-Country US Outbreak. J Trop Med Hyg 2007;76:757–68

Hughes CM, Newman FK, Davidson WB, et al. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines. Clin Vaccine Immunol 2012; 19:1116–8.

Heymann DL, Szczeniowski M, Esteves okay. The Reemergence of Monkeypox in Africa: An Evaluation of the Past Six Years. Br Med Bull 1998;54:693–702.

Hammarlund E, Lewis MW, Carter SV, et al. identified more than one diagnostic strategy to identify formerly vaccinated people with protective immunity against monkeypox. Nat Med 2005;11:1005–11.

Hughes AL, Irausquin S, Friedman R. The evolutionary biology of pox viruses. Infect Genet Evol 2010;10:50–9.

Ichihashi Y., Oie M. Epitope mosaic on the surface proteins of orthopoxvirus. Virology 1988;163:133–44.

Jezek Z, Fenner F. Human monkeypox. Monographs in virology, vol. 17. Basel (Switzerland): Karger; 1988. p. 49. table 7.

Jezek Z, Arita I, Mutombo M, et al. There are four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol 1986;123:1004–12.

Jezek Z, Clutch B, Szczeniowski MV, et al. Human monkeypox: secondary attack charges. Bull Global Health Organ 1988;66:465–70.

Jezek Z, clutch B, Dixon H. Stochastic version for the interhuman spread of monkeypox. Am J Epidemiol 1987;126:1082–92.

Jezek Z, Szczeniowski M, Paluku KM, et al., Human monkeypox: medical features of 282 sufferers. J Infect Dis 1987;156:293–8.

Kalthan E, Tenguere J, Ndjapou SG, et al. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic. Med Mal Infect 2018;48:263–8.

Kennedy JS, Gurwith M, Dekker CL, et al. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis 2011;204: 1395–402.

Khodakevich L, Widy-Wirski R, Arita I, et al. Monkeypox virus contamination in Hu guys inside the critical African Republic. Bull Soc Pathol Exot Filiales 1985;78: 311–20.

Kantele A, Chickering OK, Vapalahti O, et al. Growing ailments—the monkeypox epidemic in the Democratic Republic of the Congo. Clin Microbiol Infect 2016;22: 658–9.

Kretzschmar M, Walinga J, Teunis P, et al. Frequency of adverse events after vaccination with different vaccinia strains. PLoS Med 2006;3(8):e272. Bass J, Tack DM, McCollum AM, et al. Enhancing health care workers' ability to detect and care for patients with monkeypox in the Democratic Republic of the Congo. Int Health 2013;5:237–43.

Lane JM, Ruben FL, Neff JM, et al., Complications of Smallpox Vaccination, 1968. N Engl J Med 1969;281:1201–8.

Ministry of Health, State of Israel. A monkeypox patient was diagnosed. Available at: https://www.health.gov.il/English/News_and_Events/Spokespersons_Messages/ Pages/12102018_1.aspx. They were accessed on February 19, 2019.

McConnell S, Herman YF, Mattson DE, et al. Safety of rhesus monkeys towards monkeypox with the aid of vaccinia virus immunization. Am J Vet Res 1964;25:192–5

Marennikova SS, Seluhina EM, Malceva NN, et al. Isolation and properties of the causal agent of a brand new variola-like ailment (monkeypox) in a guy. Bull Global Health Organ 1972;46:599–611.

Moss B. Smallpox vaccines: goals of protective immunity. Immunol Rev 2011; 239:8–26.

McConnell S, Hickman RL, Wooding WL Jr., et al. Monkeypox: experimental contamination in chimpanzees (Pan satyrus) and immunization with the vaccinia virus. Am J Vet Res 1968;29:1675–8

MMWR Morb Mortal Wkly Rep2003;52(25):589–90. 50. CDC, Centers for Disease Control and Prevention. Monkeypox in the United States. 2003 Outbreak. Available at: https://www.cdc.gov/poxvirus/monkeypox/outbreak.html. Accessed February 22, 2019. 51. Public Health England. Cases of monkeypox have been confirmed in England. Available at: https://www.gov.uk/government/news/monkeypox-case-in-England. Accessed March 28, 2019.

Nakoune E, Lampaert E, Ndjapou SG, et al. A nosocomial outbreak of human monkeypox in the primary African Republic. Open forum Infect Dis 2017; 4: ofx168.

Nigeria. Accessed February 22, 2019. Nigerian CDC. Monkeypox 2019. to be had at: https://ncdc.gov.ng/sicknesses/sitreps/?cat58&name5Anpercent20Updatepercent20ofpercent20Monkeypoxp.c20Outbreakpercent20 inp. and accessed and accessed February 22, 2019.

Neff J, Modlin J, Birkhead GS, et al., and the Advisory Committee on Immunization. Practices; Armed Forces Epidemiological Board. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. Clin Infect Dis 2008; 46(Suppl 3):258–70.

Nolen LD, Osadebe L, Katoomba J, et al. prolonged human-to-human transmission at some point of a monkeypox outbreak within the Democratic Republic of the Congo. Emerg Infect Dis 2016;22:1014–21.

Osadebe L, Hughes CM, Shongo Lushima R, et al. Enhancing case definitions for surveillance of human monkeypox within the Democratic Republic of the Congo. PLoS Negl Trop Dis 2017;11:e0005857.

Oliveira JS, Figueiredo PO, Costa GB, et al. Vaccinia virus herbal infections in Brazil: the coolest, the awful, and the unsightly. Viruses 2017;9(11) [pii:E340].

Pauli G., Blumel J., Burger R., et al., Orthopox viruses: infections in humans. Transfus Med Hemother 2010; 37:351–64.

Prier JE, Sauer RM. A pox disease of monkeys. Ann N Y Acad Sci 1960;85:951–9.

Petersen E, Abubakar I, Ihekweazu C, et al. Monkeypox—enhancing public health preparedness for a rising deadly human Zoonotic epidemic danger in the wake of smallpox put up-eradication generation. Int J Infect Dis 2019;78:78–84.

Quiner CA, Moses C, Monroe BP, et al. Presumptive risk factors for monkeypox in rural groups in the Democratic Republic of the Congo. PLoS One 2017;12: e0168664.

Radoni C A, Metzger S, Dabrowski PW, et al. fatal monkeypox in wild-living sooty mangabey, Cote d’Ivoire, 2012. Emerg Infect Dis 2014;20:1009–11.

Reynolds MG, Emerson GL, Pukuta E, et al. Detection of human monkeypox in the Republic of the Congo following in-intensity network schooling. Am J Trop Med Hyg 2013;88:982–5.

Rimoin AW, Kisalu N, Kebela-Ilunga B, et al., Endemic human monkeypox, Democratic Republic of the Congo, 2001–2004. Emerg Infect Dis 2007;13:934–7.

Rimoin AW, Mulembakani PM, Johnston SC, et al. The important boom in human monkeypox occurrence occurred 30 years after smallpox vaccination campaigns were forestalled inside the Democratic Republic of Congo. Proc Natl Acad Sci United States 2010;107: 16262–7.

Shchelkunov SN, Totmenin AV, Babkin IV, et al., Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett 2001; 509:66–70.

Sklenovska´orthopoxvirus N, Van Ranst M. Emergence of monkeypox as the most essential orthopoxvirus contamination in humans. Front Public Fitness 2018;6:241.

Singh RK, Hosamani M, Balamurugan V, et al., Buffalopox: a rising and re-rising zoonosis. Anim Health Res Rev 2007;8:a hundred and five–14.

Stanford MM, McFadden G, Karupiah G, et al. Immuno pathogenesis of pox virus infections: forecasting the impending storm. Immunol cellular Biol 2007;85:93–102.

Thomassen HA, Fuller T, Asefi-Najafabady S, et al. Pathogen-host associations and she expected the variety shifts of human monkeypox in response to weather exchange in vital Africa. PLoS One 2013;8:e66071.

The Republic of Congo, 1996–1997. Emerg Infect Dis 2001;7:434.

Vaughan A, Aarons E, Astbury J, et al. Two cases of monkeypox were imported to the United Kingdom in September 2018. Euro Surveill 2018;23(38). https://doi.org/10. 2807/1560-7917.

Von Magnus P, Anderson EK, Petersen KB, et al. A pox-like sickness in cynomolgus monkeys. Acta Pathol Microbiol Scand 1959;46:156–76.

Wenner HA, Macasaet D, Kamitsuka PS, et al. Monkeypox I. is a medical, virologic, and immunologic study. Am J Epidemiol 1968;87:551–66.

WHO. Human monkeypox in Nigeria, 2018. Available at: https://www.who.int/csr/ don/05-october-2018-monkeypox-nigeria/en/. Accessed February 22, 2019.

WHO. The present-day status of human monkeypox: memorandum from a WHO meeting. Bull World Health Organ 1984;62:703–13.

WHO. 1980 The Worldwide Eradication of Smallpox: the Very Last Report of the Worldwide Commission for the Certification of Smallpox Eradication. Geneva (Switzerland): World Health Agency; 1980.

WHO. Human monkeypox (MPX) 2018. to be had at: http://www.who.int/ emergencies/illnesses/monkeypox/en/. Accessed February 22, 2019.

WHO. Human monkeypox 2019. Available at: https://www.who.int/emergencies/diseases/monkeypox/en/. Accessed February 22, 2019.

WHO. Smallpox 2019. Available at: https://www.who.int/biologicals/vaccines/ smallpox/en/. Accessed February 20, 2019.

Yinka-Ogunleye A, Aruna O, Ogoina D, et al. The re-emergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis 2018;24:1149–51.

Zumla A, Dar O, Kock R, et al. Taking forward a ’One Health approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis 2016;47:5–9.